Published paper on global health financing trends post-Ebola outbreak in collaboration with the World Health Organization, identifying a >$3bn gap in financing for new health tools alone and provide pioneering empirical evidence on the reactive nature of global health donors. Working currently with social sector clients including some of the world's largest philanthropic organizations to evaluate strategies to build late-stage clinical trial capacity for poverty-related and neglected diseases.

Gathered and analyzed information, formulated and tested hypotheses, and developed and communicated recommendations to C-Level Executives (or equivalent) in Medical Device, Healthcare, and Public/Social Sector Agencies. Projects included market landscape analysis, growth strategy, and post-merger synergies and optimizations.

Analyzed financial statements and conducted market analysis of 50+ social enterprises to recommend customized rapid scale-up strategies. Created 8 new innovator profiles to attract >$10mn in venture capital investments for companies in Kenya, Tanzania, and South Africa.